Facebook
Twitter
LinkedIn
ForwardWebinar: Prostate Cancer Update (2020)
Course Director: William J. Catalona, MD
This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2018 to May 2019. Focus will be placed on articles that have relevance to clinical practice, including both research and clinical articles.
Acknowledgments:
This educational activity is supported by independent educational grants from:
- Astellas
- AstraZeneca
- Bristol-Myers Squibb
- Genentech
- Merck
- Pfizer, Inc.
- Sanofi Genzyme
Target Audience
- Urologists
- Residents
- Advanced Practice Providers (Nurse Practitioners and Physician Assistants)
Learning Objectives
Upon completion of this activity, participants will be able to:
- Cite important new publications in this field during the past year.
- Identify the relative strengths and weaknesses of the reports.
- Appraise how new studies relate to the existing state-of-the-art in clinical practice.
- Analyze whether they and their colleagues should consider changing their practice based on the new information.
Scientific Agenda: Prostate Cancer Update Webinar (2020)
All times listed are Eastern Time
3:00 p.m. Welcome, Housekeeping Notes
3:05 p.m. Knowledge Assessment
3:10 p.m. Scientific Program - Prostate Cancer Update 2020
- Course Director/Moderator: William J. Catalona, MD
- Faculty: Douglas M. Dahl, MD; Stanley L. Liauw, MD; Stacy Loeb, MD, MSc, PhD (h.c.); Robert B. Nadler, MD; Russell Szmulewitz, MD
- Epidemiology, Etiology & Genetics
- Screening & Biopsy
- Biomarkers & Risk Stratification
- Imaging
- Active Surveillance
- Focal Therapy
- Radical Prostatectomy
- Radiation Therapy
- Advanced Disease
4:15 p.m. Audience Q&A
4:30 p.m. Webinar Adjourns - Broadcast Ends
Prostate Cancer Update (2020) will be held on virtually on Tuesday, August 11 at 3 PM EST.
***Instructions***
- Click the "Register" tab.
- If prompted, click “update your profile”. Otherwise, click “Take Course”.
- Click “Start” under Live Webinar in the Course Progress pane.
- Click "Join Webinar".
Education Council & COI Reviewer Disclosures
Education Council & COI Reviewer Disclosure_081120.pdf
AUA Office of Education Staff has nothing to disclose.
William Catalona, MD
Douglas Dahl, MD
Stanley Liauw,
Stacy Loeb, MD
Robert Nadler, MD
Russell Szmulewitz,
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA Participant Information and Policies
DISCLAIMER:
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.
REPRODUCTION PERMISSION:
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
SPECIAL ASSISTANCE/DIETARY NEEDS:
The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation